-

Jeremy Edmiston to Lead Cushman & Wakefield’s U.S. Build-To-Rent/Single Family Sector

DALLAS--(BUSINESS WIRE)--Cushman & Wakefield announced today that the real estate services firm has promoted Jeremy Edmiston to Executive Director, U.S. Lead Build-To-Rent/Single-Family Rent (BTR/SFR). In this new role, he will collaborate with the firm’s Capital Markets and Debt teams to provide unified BTR/SFR end-to-end solutions for Cushman & Wakefield’s clients.

“Over the past two years, Jeremy has proven himself a leader who is passionate about finding solutions for our BTR/SFR clients, building this new sector for our business from the ground up,” said Woody Stone, President, Multifamily Asset Services. “His passion drives him to cultivate a culture of care, and he is masterful at connecting people and opportunities for the good of all.”

Based in Dallas, Edmiston and his team oversee a property management portfolio of 9,500 homes and a pipeline of more than 2,500 homes. As the newly appointed U.S. lead, Edmiston will leverage his deep expertise, strong relationships and the Cushman & Wakefield brand to guide clients through the real estate lifecycle for their BTR/SFR assets.

“We’ve built a distinctive BTR/SFR practice over the past few years that provides end-to-end solutions for investors in the space, including property management, financing and sales,” Edmiston said. “Investment in BTR/SFR is accelerating and we expect further expansion regarding the deployment of domestic and global institutional capital to surge in coming years. Our scale, expertise, and creativity within the unified verticals will allow us to be a solid partner for this emerging sector.”

About Cushman & Wakefield

Cushman & Wakefield (NYSE: CWK) is a leading global commercial real estate services firm for property owners and occupiers with approximately 52,000 employees in approximately 400 offices and 60 countries. In 2022, the firm reported revenue of $10.1 billion across its core services of property, facilities and project management, leasing, capital markets, and valuation and other services. It also receives numerous industry and business accolades for its award-winning culture and commitment to Diversity, Equity and Inclusion (DEI), Environmental, Social and Governance (ESG) and more. For additional information, visit www.cushmanwakefield.com.

Contacts

Cushman & Wakefield

NYSE:CWK

Release Summary
Cushman & Wakefield announced today that Jeremy Edmiston will lead the real estate services firm's U.S. Build-To-Rent/Single-Family Rent sector.
Release Versions
Hashtags

Contacts

Social Media Profiles
More News From Cushman & Wakefield

Cushman & Wakefield: U.S. Legal Sector Leasing Hits Record 7.3 Million Square Feet in Q2 2026 as Law Firms Expand Footprints

NEW YORK--(BUSINESS WIRE)--U.S. legal sector leasing reached a quarterly record of 7.3 million square feet (sf) in the second quarter of 2026, surpassing the previous quarterly high by 23%, according to a new report from Cushman & Wakefield. First-half legal leasing reached nearly 12.2 million sf, up 17% year over year, as law firm demand continued to contribute to the recovery in U.S. office leasing. “The legal sector is showing a clear preference for larger footprints, with expansion acti...

Cushman & Wakefield Releases 2026 Data Center Development Cost Guide, Citing 21% Rise in Per-MW Construction Costs

NEW YORK--(BUSINESS WIRE)--Cushman & Wakefield (NYSE: CWK), a leading global commercial real estate services firm, has published its 2026 Data Center Development Cost Guide, revealing that data center construction costs have risen an average of 21% per megawatt (MW) since the previous edition was published in the fourth quarter of 2024. Covering markets across the United States and Canada, the guide provides a comprehensive overview of data center development economics spanning land acquisi...

Cushman & Wakefield: U.S. Life Sciences Market Moves Toward Rebalancing as Capital Returns and New Development Slows

NEW YORK--(BUSINESS WIRE)--The U.S. life sciences real estate sector is moving toward a gradual rebalancing as development activity contracts, investment sales recover and funding conditions strengthen, according to the latest Life Sciences Update from Cushman & Wakefield. While elevated vacancy and softer rents continue to weigh on near-term fundamentals, a reduced construction pipeline and improving demand indicators are positioning the market for healthier long-term growth. U.S. life sci...
Back to Newsroom